First 100 CustomCornea commercial eyes.
OBJECTIVE
With the advent of wavefront-guided custom abalation we not only try to reach a target of 20/20 vision, but strive for improvement in what has always been most important--the quality of this vision.


RESULTS
Insights are presented, based on clinical experience at Durrie Vision with our first 100 commercial CustomCornea eyes. We highlight key points for preparing a clinical practice for this new technology, such as staff training, marketing, and pricing. We discuss technical aspects such as patient selection and target adjustment as they relate to the Alcon LADARWave system.


CONCLUSIONS
In our practice we have thus far had clinical success with CustomCornea; patient acceptance has been high, and by closely monitoring our first few patients we were able to reduce the number of future enhancements.
Durrie
Daniel S
DS
Durrie Vision, Overland Park, KS 66211, USA. ddurrie@durrievision.com
D001251:Astigmatism / Q000191:economics / Q000601:surgery*; D003315:Cornea / Q000601:surgery*; D003365:Costs and Cost Analysis; D006282:Health Personnel / Q000193:education; D006801:Humans; D020731:Keratomileusis, Laser In Situ / Q000191:economics / Q000379:methods*; D054018:Lasers, Excimer; D008389:Marketing of Health Services; D009216:Myopia / Q000191:economics / Q000601:surgery*; D010342:Patient Acceptance of Health Care; D018579:Patient Selection; D018903:Photorefractive Keratectomy / Q000191:economics / Q000379:methods*; D010818:Practice Patterns, Physicians' / Q000592:standards*